Literature DB >> 30556385

Detection of bacterial pathogens in sterile fluids with the FilmArray Meningitis/Encephalitis identification system.

F Cobo1, J Borrego, J Rodríguez-Granger, A Puertas, A Sampedro, J M Navarro-Marí.   

Abstract

©The Author 2019. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Entities:  

Mesh:

Year:  2018        PMID: 30556385      PMCID: PMC6372964     

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


Sir, Rapid detection of pathogens in serious infections is a very important issue in terms of establishment of correct antimicrobial therapy, increase of patient survival, shorten hospital stay, and reduce health care costs [1]. Due to several circumstances, the culture of the sample may be negative or the result may be delayed, so rapid and sensitive identification techniques could be more useful and to serve as alternative in the management of the disease. Recently, we were confronted with three cases diagnosed by the FilmArray Meningitis/Encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT, USA) [2]. We would like to highlight the possibility of use of this technique for pathogen detection in some sterile fluid samples. Case 1.- A 76-year-old man presented with a chronic pleural effusion. His clinical history was remarkable for a gastric carcinoma, diabetes mellitus and chronic pulmonary obstructive disease. The pleural fluid was drained and sent to the microbiology laboratory for culture. Due to the absence of pathogen growth and the poor clinical situation of the patient, a FilmArray ME panel was performed and a positive result for Streptococcus agalactiae was obtained. The subsequent subculture from the thioglycollate fluid also demonstrates S. agalactiae growth. The patient was treated with amoxycillin (500 mg/8 h) for 10 days and quickly improved. Case 2.- A 3-year-old man presented pneumonia and pleural effusion. On his vaccination history, the pneumococcal vaccine was not included. The pleural fluid was drained and sent to the microbiology laboratory for culture. The sample culture was negative, and both a FilmArray ME panel and a determination of pneumococcal antigen (Uni-Gold S. pneumoniae, Trinity Biotech, Carlsbad, CA, USA) in the pleural fluid were performed, with a positive result for Streptococcus pneumoniae in both cases. The child was treated with cefotaxime during 10 days with a positive outcome at 3 month of follow-up. Case 3.- A 33-year-old female was admitted due to fever and headache. The patient was pregnant with a twin pregnancy of 14 weeks. An abdominal ultrasound was performed and a diagnosis of single fetal death twin was established. A vaginal bleeding was demonstrated and an amniocentesis technique was carried out in order to discard chorioamnionitis. The amniotic fluid from the dead fetus was sent to the microbiology laboratory for analysis with suspicion of Listeria infection. An initial FilmArray ME panel was performed and a positive result for Listeria monocytogenes was obtained. On the second day of incubation the growth of L. monocytogenes was reported in pure culture. A sample of placental biopsy was also taken and sent to study. The sample resulted in a negative culture after 5 days of incubation. A FilmArray technique was also performed for this sample being, however, positive to L. monocytogenes. The FilmArray ME panel is a multiplexed nucleic acid test used for the simultaneous qualitative detection and identification of multiple viral, yeast and bacterial nucleic acid targets in cerebrospinal fluid (CSF) samples [2]. This panel is a rapid tool for detection of 14 pathogens (ME producers) directly from CSF specimens. Bacteria included in this panel are Escherichia coli K1, Haemophilus influenzae, Neisseria meningitidis, S. pneumoniae, S. agalactiae, and L. monocytogenes. A multicenter evaluation of this panel demonstrated a sensitivity or positive percentage of agreement of 100% for 9 of 14 pathogens [2]. Sensitivity for L. monocytogenes was not obtained because of this microorganism was not observed in the study [2]. However a study using the FilmArray technology showed a positive result for L. monocytogenes in a boy with symptomatology of meningoencephalitis with negative cultures (from blood and CSF) [3]. Other recent studies have focused on the use of this technology both in adults and children [4, 5]. As in our cases, some authors have reported the use of FilmArray Blood Culture Identification multiplex PCR system for pathogen detection from both synovial and pleural fluid, detecting S. pyogenes and S. pneumoniae, respectively [6]. Other studies have used FilmArray test for pathogen detection in other clinical specimens such as pleural, synovial and ascitic fluids [7-9]. Although these fluids are still not optimized as specimens for the detection of pathogens in the ME panel, the present report shows the potential utility of this panel for the rapid diagnosis of a variety of infectious microorganisms from direct testing of clinical specimens.

FUNDING

None to declare

CONFLICT OF INTEREST

The author declare that they have no conflicts of interest
  2 in total

1.  Evaluation of FilmArray ME panel for the rapid diagnosis of meningitis-encephalitis in emergency departments.

Authors:  Javier Ena; Raisa Goretti Afonso-Carrillo; Miriam Bou-Collado; Maria Dolores Reyes-Jara; Roser Navarro-Soler; David de Haedo-Sanchez; Carmen Martinez-Peinado; Barbara Gomez-Alonso; Francisco Arjona-Zaragozi
Journal:  Intern Emerg Med       Date:  2021-01-05       Impact factor: 3.397

2.  Development and verification of a discriminate algorithm for diagnosing post-neurosurgical bacterial meningitis-A multicenter observational study.

Authors:  Guanghui Zheng; Xufeng Ji; Xiaochen Yu; Min Liu; Jing Huang; Lina Zhang; Dawen Guo; Guojun Zhang
Journal:  J Clin Lab Anal       Date:  2019-10-10       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.